一种新合成的二碳氧化氧赫巴林有效减轻瘤生长和转移
Li Li1, Uri Barash2, Neta Ilan2
1Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen 518057, China.
Cells
|February 9, 2024
概括
一种新型的肝酶抑制剂,化合物XII,在各种癌症模型中显示出强大的抗瘤效应. 这种候选药物显著抑制瘤生长和转移,需要进行临床研究.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 药物发现 药物发现 药物发现
背景情况:
- 肝酶 (Hpa1) 通过重塑细胞外基质,对瘤生长,转移和血管化至关重要.
- 恶性瘤中Hpa1表达升高与患者预后不佳相关,推动了寻找有效抑制剂的研究.
- 肝素/HS模仿剂是有前途的肝酶抑制剂,目前正在临床试验中.
研究的目的:
- 合成和评估新型二氧化氧氨酸 (DCoxHs) 作为潜在的抗癌剂.
- 在临床前瘤模型中评估化合物XII的疗效.
- 研究XII化合物抗瘤活性背后的机制.
主要方法:
- 二碳氧化氧赫巴林 (DCoxHs) 的合成和表征.
- 在胰腺癌,乳腺癌,中瘤和髓瘤的临床前模型中对化合物XII的评估.
- 在动物模型中评估瘤生长抑制 (TGI),存活率和转移.
- 研究化合物XII对肝酶蛋白水平,细胞吸收和激活的影响.
主要成果:
- 化合物XII在多种癌症模型中表现出显著的瘤生长抑制 (21-70%) 和延长生存期.
- 在切除后的 ортотоп乳腺癌模型中观察到自发转移的显著减少.
- 初步发现表明,化合物XII也可能降低肝酶蛋白水平,并抑制其细胞吸收和激活,超出酶抑制.
结论:
- 化合物XII是一种新的DCoxH,对各种固体瘤和髓瘤表现出强大的临床前抗癌活性.
- 该化合物有效地抑制瘤生长,转移,并可能通过多种机制起作用,包括肝酶蛋白调节.
- 这些临床前发现强烈支持将化合物XII推向癌症患者的临床试验.
关键词:
乳腺癌,乳腺癌.化学修饰的黑巴林是一种化学修饰的黑巴林.肝酶的使用方法半质瘤 (Mesothelioma) 是一种中质瘤.转移 转移 转移 转移胰腺癌是一种胰腺癌.初级瘤生长的主要原因抑制瘤生长 抑制瘤生长更多相关视频
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
1.5K
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.7K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
698
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
698
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K